Article: Genaera Announces Positive Interim EVIZON(TM) Phase II (MSI-1256F-208) AMD Data at Annual ARVO Meeting.

Article: Genaera Presents Positive Preliminary Clinical Results for ...
PR Newswire;  October 19, 2005 ;     700+ words ... ... degeneration (AMD). EVIZON with concomitant PDT was well tolerated in ... presented for 40mg or 20mg of EVIZON with concomitant PDT compared with PDT-alone ... Subjects treated with 40mg of EVIZON and concomitant PDT gained an average of 0 ...

Article: Genaera Announces Preliminary Phase II Data Showing ...
PR Newswire;  October 11, 2005 ;     700+ words ... ... Vancouver, Canada). EVIZON with concomitant PDT was well tolerated in ... exploratory trial of EVIZON with concomitant PDT for wet AMD," commented ... preliminary safety of EVIZON with concomitant PDT. As a result, we are ...

Article: Genaera Initiates Phase III Macular Degeneration Clinical Trial ...
PR Newswire;  June 30, 2005 ;     700+ words ... ... three different doses of EVIZON (10 mg, 20 mg or 40 mg) with initial concomitant PDT treatment in 45 subjects ... systemically administered EVIZON before and after photodynamic ... safety of administering concomitant PDT with EVIZON. Additional results ...

Article: Genaera Completes Special Protocol Assessment with FDA for ...
PR Newswire;  June 27, 2005 ;     700+ words ... ... patients may continue to receive EVIZON as needed for up to one additional ... three different doses of EVIZON (10 mg, 20 mg or 40 mg) with initial concomitant PDT with Visudyne(R) (QLT ... systemically administered EVIZON before and after PDT with ...

Article: Genaera presents positive preliminary clinical results for ...
M2 Presswire;  October 20, 2005 ;     700+ words ... ... preliminary clinical results for EVIZON and U.S. Biodefense, Inc ... trial (MSI-1256F-208) of EVIZON(TM) (squalamine lactate ... macular degeneration (AMD). EVIZON with concomitant PDT was well tolerated in all subjects ...

Article: Genaera Corporation Presents Clinical Results for ...
PR Newswire;  July 18, 2005 ;     700+ words ... ... U.S. Phase II clinical trials with EVIZON(TM) (squalamine lactate) for the ... AMD), also known as "wet" AMD. EVIZON is the leading systemically delivered ... safety trial (MSI-1256F-207) with EVIZON. In this trial 10, 20, or 40 mg doses ...

Article: Genaera, FDA Reach SPA For Evizon AMD Phase III.
BIOWORLD Today;  November 3, 2009 ;     700+ words ... ... out its pivotal development plans for Evizon (squalamine lactate), courtesy of a ... Among that gaggle of treatment options, Evizon stands out because it's a systemic agent ... recruited to date have two affected eyes." Evizon's global registration studies will follow ...